Form 8-A12B - Registration of securities [Section 12(b)]:
SEC Accession No. 0001193125-21-190157
Filing Date
2021-06-14
Accepted
2021-06-14 16:56:31
Documents
1

Document Format Files

Seq Description Document Type Size
1 8-A12B d152418d8a12b.htm 8-A12B 12450
  Complete submission text file 0001193125-21-190157.txt   13461
Mailing Address 400 EAST JAMIE COURT SUITE 301 SOUTH SAN FRANCISCO CA 94080
Business Address 400 EAST JAMIE COURT SUITE 301 SOUTH SAN FRANCISCO CA 94080 650 695-0677
Lyell Immunopharma, Inc. (Filer) CIK: 0001806952 (see all company filings)

EIN.: 833006753 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-A12B | Act: 34 | File No.: 001-40502 | Film No.: 211015237
SIC: 2834 Pharmaceutical Preparations